Perfil
Roger W.
Brimblecombe is currently a Director at 2gether NHS Foundation Trust.
He previously held Chairman positions at CeNeS Pharmaceuticals Plc, Vanguard Medica Plc, Oxford Asymmetry International Plc, EyePoint Pharmaceuticals, Inc., and Core Group Ltd. He was also a Director at Vertex Pharmaceuticals, Inc. for 17 years.
Brimblecombe has a graduate and doctorate degree from the University of Bristol.
Cargos activos de Roger W. Brimblecombe
| Empresas | Cargo | Inicio |
|---|---|---|
2gether NHS Foundation Trust
2gether NHS Foundation Trust Medical/Nursing ServicesHealth Services Provides health care services | Director/Miembro de la Junta | 27/05/2009 |
Antiguos cargos conocidos de Roger W. Brimblecombe.
| Empresas | Cargo | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Director/Miembro de la Junta | 13/05/2010 |
Tissue Science Laboratories Ltd.
Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Develops and markets tissue implant products | Director/Miembro de la Junta | 01/05/2008 |
| EYEPOINT, INC. | Presidente | 01/01/2007 |
Vertex Pharmaceuticals (Europe) Ltd.
Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Supplies pharmaceutical products | Director/Miembro de la Junta | 02/01/2005 |
Oxford Asymmetry International Plc
Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Presidente | 01/01/2000 |
Formación de Roger W. Brimblecombe.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
CeNeS Pharmaceuticals Plc
CeNeS Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the discovery and development of drugs | Health Technology |
Vanguard Medica Plc
Vanguard Medica Plc Miscellaneous Commercial ServicesCommercial Services Provides research and development in neosciences | Commercial Services |
Tissue Science Laboratories Ltd.
Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Develops and markets tissue implant products | Health Technology |
Oxford Asymmetry International Plc
Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals (Europe) Ltd.
Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
Core Group Ltd.
Core Group Ltd. Finance/Rental/LeasingFinance Provides construction equipment rental services | Finance |
Smithkline & French Laboratories US, Inc. | |
2gether NHS Foundation Trust
2gether NHS Foundation Trust Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
- Bolsa de valores
- Insiders
- Roger W. Brimblecombe
















